Association between the change in 2-AG level and reduction of depressive and anxious symptoms immediately following completion of a 2-week long rTMS intervention schedule showed a strong trend, and 2 weeks after completion of the rTMS sessions there was a significant association between 2-AG level changes and decreased depression, anxiety, and anhedonia symptoms as well as neurocognitive symptoms as reflected by the number of errors in the SCWT-CW task.
← all excerpts
Peripheral endocannabinoid serum level in association with repetitive transcranial magnetic stimulation (rTMS) treatment in patients with major depressive disorder.
1
—
—